Göran R Boeckel1, Barbara E Ehrlich2. 1. Department of Pharmacology, Yale University, New Haven, CT, United States; Institut für Physiologie, Universität zu Lübeck, Ratzeburger Allee 160, D-23562 Lübeck, Germany. 2. Department of Pharmacology, Yale University, New Haven, CT, United States; Institut für Physiologie, Universität zu Lübeck, Ratzeburger Allee 160, D-23562 Lübeck, Germany. Electronic address: barbara.ehrlich@yale.edu.
Abstract
Neuronal Calcium Sensor-1 (NCS-1) is a highly conserved calcium binding protein which contributes to the maintenance of intracellular calcium homeostasis and regulation of calcium-dependent signaling pathways. It is involved in a variety of physiological cell functions, including exocytosis, regulation of calcium permeable channels, neuroplasticity and response to neuronal damage. Over the past 30 years, continuing investigation of cellular functions of NCS-1 and associated disease states have highlighted its function in the pathophysiology of several disorders and as a therapeutic target. Among the diseases that were found to be associated with NCS-1 are neurological disorders such as bipolar disease and non-neurological conditions such as breast cancer. Furthermore, alteration of NCS-1 expression is associated with substance abuse disorders and severe side effects of chemotherapeutic agents. The objective of this article is to summarize the current body of evidence describing NCS-1 and its interactions on a molecular and cellular scale, as well as describing macroscopic implications in physiology and medicine. Particular attention is paid to the role of NCS-1 in development and prevention of chemotherapy induced peripheral neuropathy (CIPN).
Neuronal Calcium Sensor-1 (n class="Gene">NCS-1) is a highly conserved calcium binding protein which contributes to the maintenance of intracellular calcium homeostasis and regulation of calcium-dependent signaling pathways. It is involved in a variety of physiological cell functions, including exocytosis, regulation of calcium permeable channels, neuroplasticity and response to neuronal damage. Over the past 30 years, continuing investigation of cellular functions of NCS-1 and associated disease states have highlighted its function in the pathophysiology of several disorders and as a therapeutic target. Among the diseases that were found to be associated with NCS-1 are neurological disorders such as bipolar disease and non-neurological conditions such as breast cancer. Furthermore, alteration of NCS-1 expression is associated with substance abuse disorders and severe side effects of chemotherapeutic agents. The objective of this article is to summarize the current body of evidence describing NCS-1 and its interactions on a molecular and cellular scale, as well as describing macroscopic implications in physiology and medicine. Particular attention is paid to the role of NCS-1 in development and prevention of chemotherapy induced peripheral neuropathy (CIPN).
Authors: Amélie Piton; Jacques L Michaud; Huashan Peng; Swaroop Aradhya; Julie Gauthier; Laurent Mottron; Nathalie Champagne; Ronald G Lafrenière; Fadi F Hamdan; Ridha Joober; Eric Fombonne; Claude Marineau; Patrick Cossette; Marie-Pierre Dubé; Pejmun Haghighi; Pierre Drapeau; Philip A Barker; Salvatore Carbonetto; Guy A Rouleau Journal: Hum Mol Genet Date: 2008-09-18 Impact factor: 6.150
Authors: Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén Journal: Science Date: 2015-01-23 Impact factor: 47.728
Authors: Elena Dragicevic; Christina Poetschke; Johanna Duda; Falk Schlaudraff; Stephan Lammel; Julia Schiemann; Michael Fauler; Andrea Hetzel; Masahiko Watanabe; Rafael Lujan; Robert C Malenka; Joerg Striessnig; Birgit Liss Journal: Brain Date: 2014-06-16 Impact factor: 13.501
Authors: Robert D Burgoyne; Nordine Helassa; Hannah V McCue; Lee P Haynes Journal: Cold Spring Harb Perspect Biol Date: 2019-05-01 Impact factor: 10.005
Authors: Tamra Reall; Susanne Kraus; Cynthia L Goodman; Joseph Ringbauer; Sven Geibel; David Stanley Journal: In Vitro Cell Dev Biol Anim Date: 2019-08-13 Impact factor: 2.416
Authors: Jonathan E Apasu; Daniel Schuette; Ryan LaRanger; Julia A Steinle; Lien D Nguyen; Henrike K Grosshans; Meiling Zhang; Wesley L Cai; Qin Yan; Marie E Robert; Michael Mak; Barbara E Ehrlich Journal: FASEB J Date: 2018-12-28 Impact factor: 5.191
Authors: Alice H L Bong; Mélanie Robitaille; Michael J G Milevskiy; Sarah J Roberts-Thomson; Gregory R Monteith Journal: Mol Oncol Date: 2019-11-11 Impact factor: 6.603
Authors: Henrike K Grosshans; Tom T Fischer; Julia A Steinle; Allison L Brill; Barbara E Ehrlich Journal: Mol Oncol Date: 2020-04-28 Impact factor: 6.603